Dimerix signs up first patient for ‘highly significant’ paediatric clinical trial
Dimerix Limited (ASX:DXB), a Melbourne-based biopharmaceutical company, has started recruitment for its first…
Dimerix Limited (ASX:DXB)
About Dimerix Limited
Key Information
DXB In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 22/01/2025 | Application for quotation of securities - DXB | 15.57KB | 340 |
| 16/01/2025 | Application for quotation of securities - DXB | 15.57KB | 771 |
| 16/01/2025 | Price Sensitive PS First Paediatric Patient Recruited for ACTION3 | 387.81KB | 10K |
| 13/01/2025 | Application for quotation of securities - DXB | 15.57KB | 621 |
| 07/01/2025 | Investor Presentation | 7.1MB | 8.2K |
| 07/01/2025 | Price Sensitive PS Dimerix enters Development and License Agreement for Japan | 357.12KB | 52K |
| 30/12/2024 | Price Sensitive PS DMX-200 ACTION3 Phase 3 Trial Part 2 Recruitment Complete | 350.16KB | 48K |
| 16/12/2024 | Application for quotation of securities - DXB | 15.57KB | 566 |